Craft

Wantai BioPharm

Stock Price

¥73.4

2024-10-29

Market Capitalization

¥92.9 B

2024-10-28

Revenue

¥1.7 B

FY, 2025

Wantai BioPharm Summary

Company Summary

Overview
Wantai BioPharm (also known as Beijing Wantai Biological Pharmacy Enterprise, 北京万泰生物药业股份有限公司) is a company engaged in the research, development, and production of biological diagnostic reagents and vaccines. It offers automated immunoassays, clinical chemistry, vaccines, diagnostic tests, and other products.
Type
Public
Status
Active
Founded
1991
HQ
Beijing, CN | view all locations
Website
https://www.ystwt.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

LocationsView all

2 locations detected

  • Beijing, Beijing Shi HQ

    China

    No.31 Kexueyuan Road, Changping District

  • Xiamen, Fujian

    China

    Shanbianhong, Haicang District

Wantai BioPharm Financials

Summary Financials

Revenue (Q1, 2026)
¥518.1M
Gross profit (Q1, 2026)
¥360.4M
Net income (Q1, 2026)
(¥44.9M)
Cash (Q1, 2026)
¥2.4B
EBIT (Q1, 2026)
(¥69.3M)
Enterprise value
$90.9B

Footer menu